{"id":"https://openalex.org/W2061161517","doi":"https://doi.org/10.1038/clpt.1981.10","title":"Phenytoin-salicylate interaction","display_name":"Phenytoin-salicylate interaction","publication_year":1981,"publication_date":"1981-01-01","ids":{"openalex":"https://openalex.org/W2061161517","doi":"https://doi.org/10.1038/clpt.1981.10","mag":"2061161517","pmid":"https://pubmed.ncbi.nlm.nih.gov/7460475"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.1981.10","doi":"https://doi.org/10.1038/clpt.1981.10","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.1981.10","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113729288","display_name":"Roger Leonard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I88694374","display_name":"Marshall University","ror":"https://ror.org/02erqft81","country_code":"US","type":"education","lineage":["https://openalex.org/I88694374"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roger F Leonard","raw_affiliation_strings":["The Departments of Pharmacology and Medicine, Marshall University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Pharmacology and Medicine, Marshall University School of Medicine","institution_ids":["https://openalex.org/I88694374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030210758","display_name":"Peter J. Knott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I88694374","display_name":"Marshall University","ror":"https://ror.org/02erqft81","country_code":"US","type":"education","lineage":["https://openalex.org/I88694374"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J Knott","raw_affiliation_strings":["The Departments of Pharmacology and Medicine, Marshall University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Pharmacology and Medicine, Marshall University School of Medicine","institution_ids":["https://openalex.org/I88694374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026517567","display_name":"Gary O'Neal Rankin","orcid":"https://orcid.org/0000-0002-5385-3512","observed_orcids":["https://orcid.org/0000-0002-5385-3512"]},"institutions":[{"id":"https://openalex.org/I88694374","display_name":"Marshall University","ror":"https://ror.org/02erqft81","country_code":"US","type":"education","lineage":["https://openalex.org/I88694374"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary O Rankin","raw_affiliation_strings":["The Departments of Pharmacology and Medicine, Marshall University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Pharmacology and Medicine, Marshall University School of Medicine","institution_ids":["https://openalex.org/I88694374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103440073","display_name":"Donald S. Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I88694374","display_name":"Marshall University","ror":"https://ror.org/02erqft81","country_code":"US","type":"education","lineage":["https://openalex.org/I88694374"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald S Robinson","raw_affiliation_strings":["The Departments of Pharmacology and Medicine, Marshall University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Pharmacology and Medicine, Marshall University School of Medicine","institution_ids":["https://openalex.org/I88694374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108599684","display_name":"Donald E. Melnick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I88694374","display_name":"Marshall University","ror":"https://ror.org/02erqft81","country_code":"US","type":"education","lineage":["https://openalex.org/I88694374"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald E Melnick","raw_affiliation_strings":["The Departments of Pharmacology and Medicine, Marshall University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Pharmacology and Medicine, Marshall University School of Medicine","institution_ids":["https://openalex.org/I88694374"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113729288"],"corresponding_institution_ids":["https://openalex.org/I88694374"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":3.2026,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.91662961,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"29","issue":"1","first_page":"56","last_page":"60"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.4894999861717224,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.4894999861717224,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.219200000166893,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.14659999310970306,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/salicylates","display_name":"salicylates","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8870000243186951},{"id":"https://openalex.org/keywords/protein-binding-displacement","display_name":"protein binding displacement","score":0.8970000147819519},{"id":"https://openalex.org/keywords/free-drug-fraction","display_name":"free drug fraction","score":0.800000011920929},{"id":"https://openalex.org/keywords/salivary-drug-concentration","display_name":"salivary drug concentration","score":0.8629999756813049},{"id":"https://openalex.org/keywords/serum-phenytoin-concentration","display_name":"serum phenytoin concentration","score":0.8569999933242798},{"id":"https://openalex.org/keywords/anticonvulsant-therapy","display_name":"anticonvulsant therapy","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.9668056964874268},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.6316826343536377},{"id":"https://openalex.org/C2781233306","wikidata":"https://www.wikidata.org/wiki/Q5500236","display_name":"Free fraction","level":3,"score":0.568098783493042},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5063694715499878},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4809257686138153},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45846378803253174},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.42137858271598816},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41595539450645447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3651955723762512},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.333312451839447},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3285418748855591},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2714509963989258},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.20862430334091187},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012463","descriptor_name":"Saliva","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/clpt.1981.10","doi":"https://doi.org/10.1038/clpt.1981.10","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.1981.10","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:7460475","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7460475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W149775432","https://openalex.org/W1553368037","https://openalex.org/W1796303466","https://openalex.org/W1817073749","https://openalex.org/W1985138005","https://openalex.org/W1996514181","https://openalex.org/W1998033119","https://openalex.org/W2051074589","https://openalex.org/W2061145382","https://openalex.org/W2401434946"],"related_works":["https://openalex.org/W2047601649","https://openalex.org/W2051074589","https://openalex.org/W2059559271","https://openalex.org/W2417590500","https://openalex.org/W2408670353","https://openalex.org/W1978033509","https://openalex.org/W2408996300","https://openalex.org/W1925440308","https://openalex.org/W2154656989","https://openalex.org/W210889380"],"abstract_inverted_index":{"Ten":[0],"healthy":[1],"adult":[2],"subjects":[3,29],"took":[4,30],"a":[5,16,36,166],"single":[6],"daily":[7],"dose":[8,40,70,146,219],"of":[9,33,72,77,185,193,220,231],"phenytoin":[10,19,58,78,89,107,124,176,204,210,221],"for":[11,50],"9":[12],"days":[13],"to":[14,97,114,134,164],"achieve":[15],"steady-state":[17],"serum":[18,61,169,173],"concentration":[20,171,205,211],"in":[21,35,142,152,200],"the":[22,84,143,197,201,218],"therapeutic":[23],"range.":[24],"While":[25],"continuing":[26],"on":[27],"phenytoin,":[28,186],"increasing":[31],"doses":[32],"salicylate":[34,62,80,86,145,159,170,180,215],"step-wise":[37],"fashion,":[38],"each":[39,69],"(325,":[41],"650,":[42],"and":[43,55,60,67,123,172],"975":[44],"mg)":[45],"given":[46],"every":[47],"4":[48],"hr":[49],"48":[51],"hr.":[52],"Serum":[53,88,208],"(total)":[54],"salivary":[56,106,175],"(free)":[57],"concentrations":[59,63],"were":[64],"measured":[65],"before":[66],"after":[68],"level":[71],"salicylate.":[73],"Protein":[74],"binding":[75,183],"displacement":[76,184],"by":[79],"occurred":[81],"only":[82],"at":[83],"highest":[85,144],"dose.":[87],"control":[90],"levels":[91,108],"fell":[92],"from":[93,110,130],"13.5":[94],"+/-":[95,99,112,116,132,136],"1.2":[96],"10.3":[98],"0.8":[100],"micrograms/ml":[101,118],"(p":[102,119,138],"less":[103,120,139],"than":[104,121,140],"0.01),":[105],"rose":[109],"0.97":[111],"0.09":[113],"1.13":[115],"0.12":[117],"0.05),":[122],"free":[125,202],"fraction":[126],"(salivary/serum":[127],"ratio)":[128],"increased":[129],"7.14":[131],"0.34%":[133],"10.66":[135],"0.57%":[137],"0.01)":[141],"periods.":[147],"There":[148],"was":[149,206],"no":[150],"difference":[151],"these":[153],"parameters":[154],"during":[155,214],"low-dose":[156],"or":[157,174],"intermediate-dose":[158],"therapy.":[160],"Linear-regression":[161],"analysis":[162],"failed":[163],"show":[165],"relationship":[167],"between":[168],"concentration.":[177],"Although":[178],"high-dose":[179],"induced":[181],"protein":[182],"it":[187],"is":[188,192],"unlikely":[189],"that":[190],"this":[191],"clinical":[194],"importance":[195],"since":[196],"rise":[198],"(16%)":[199],"(salivary)":[203],"small.":[207],"total":[209],"may":[212],"fall":[213],"therapy":[216],"but":[217],"should":[222],"not":[223],"be":[224],"altered":[225],"unless":[226],"there":[227],"are":[228],"overt":[229],"signs":[230],"toxicity.":[232]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}